Preoperative levels of MV TF PCA are increased in patients with ovarian cancer.
MV TF PCA is not correlated with the tumor stage.
Addition of MV TF PCA confers diagnostic benefit to D-dimer and CA-125.
Assessment of MV TF PCA cannot be replaced by quantification of plasma TF antigen.